Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M336Revenue $M8.5Net Margin (%)-1,484.1Altman Z-Score-0.8
Enterprise Value $M233EPS $-1.3Operating Margin %-1,479.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score16.8Pre-tax Margin (%)-1,475.1Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %--Quick Ratio3.6Cash flow > EarningsN
Price/Sales37.95-y EBITDA Growth Rate %--Current Ratio4.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-81.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-103.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M105ROIC % (ttm)-24,375.6Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KERXSeth Klarman 2015-06-30 Add0.57%$9.32 - $12.73
($10.75)
$ 3.17-71%Add 15.24%25,791,678
KERXSeth Klarman 2015-03-31 Add0.88%$10.87 - $14.68
($12.86)
$ 3.17-75%Add 22.30%22,380,200
KERXSeth Klarman 2014-09-30 Add1.87%$12.71 - $18.19
($15.32)
$ 3.17-79%Add 73.62%18,300,000
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
($14.16)
$ 3.17-78%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
($14.98)
$ 3.17-79%New holding6,310,850
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Adams BrianVP and General Counsel 2016-01-15Sell1,322$3.3-3.33view
Adams BrianVP and General Counsel 2016-01-06Sell3,004$5.16-38.18view
Madison GregPresident and CEO 2016-01-06Sell4,261$4.83-33.95view
Adams BrianVP and General Counsel 2016-01-06Sell3,004$4.83-33.95view
Madison GregPresident and CEO 2015-11-09Sell1,638$5.18-38.42view
Holmes Scott ACFO 2015-11-04Buy5,000$5.33-40.15view
Adams BrianVP and General Counsel 2015-10-15Sell1,011$4.01-20.45view
Holmes Scott ACFO 2015-08-21Buy5,000$5.72-44.23view
Madison GregPresident and CEO 2015-08-20Buy9,984$5.69-43.94view
Neylan John F.Chief Medical Officer 2015-08-12Buy10,000$6.2-48.55view

Quarterly/Annual Reports about KERX:

    News about KERX:

    Articles On GuruFocus.com
    Klarman Gives Insight on Keryx Biopharmaceuticals Investment Jan 26 2016 
    Seth Klarman Blames Market, Investments for Rare Down Year Jan 25 2016 
    David Abrams Buys Stake in Heavy Equipment Company Dec 15 2015 
    Why Seth Klarman Keeps Buying Keryx Biopharma Nov 03 2015 
    Seth Klarman Raises Position in Keryx Biopharmaceuticals Oct 21 2015 
    Seth Klarman Buys Pharmaceutical Company's Shares to Fund Drug Launch Oct 12 2015 
    Is Seth Klarman right about Keryx Inc.? Jun 25 2015 
    Seth Klarman Buys Pioneer Natural Resources, SunEdison Semiconductor Ltd, Atara Biotherapeutics Inc, May 15 2015 
    Analysts Positive on Keryx Biopharmaceuticals, Inc. Despite Weak Prescription Data May 05 2015 
    Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 

    More From Other Websites
    Klarman Gives Insight on Keryx Biopharmaceuticals Investment Jan 26 2016
    Keryx Biopharmaceuticals, Inc. – Value Analysis (NASDAQ:KERX) : January 4, 2016 Jan 04 2016
    Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : December 31,... Dec 31 2015
    Keryx Biopharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday,... Dec 22 2015
    Keryx Biopharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday,... Dec 22 2015
    XBI Recovers from Its Slump Dec 21 2015
    Technical Briefing on Biotechnology Equities -- Keryx Biopharma, Cytokinetics, Curis, and BioTime Dec 17 2015
    Equities Lead Investor Sentiment - Research Reports on TriNet Group, Xencor, Keryx... Dec 11 2015
    KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers,... Dec 10 2015
    Keryx Announces Appointment of John P. Butler to its Board of Directors Dec 10 2015
    Keryx Announces Appointment of John P. Butler to its Board of Directors Dec 10 2015
    KERYX BIOPHARMACEUTICALS INC Financials Dec 08 2015
    Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : December 8,... Dec 08 2015
    Hedge Funds Are Selling Keryx Biopharmaceuticals (KERX) Dec 05 2015
    Keryx Biopharmaceuticals Announces Webcast of Presentation at Oppenheimer's 26th Annual Healthcare... Dec 01 2015
    Keryx Biopharmaceuticals Announces Participation at Two Upcoming Investor Conferences Nov 03 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK